V030-3515 Screening compound: 2-[4-(3-chlorophenyl)-1-(4-fluorophenyl)-7-oxo-3-phenyl-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-(3-methoxypropyl)acetamide

V030-3515 Screening compound: 2-[4-(3-chlorophenyl)-1-(4-fluorophenyl)-7-oxo-3-phenyl-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-(3-methoxypropyl)acetamide
V030-3515 Screening compound: 2-[4-(3-chlorophenyl)-1-(4-fluorophenyl)-7-oxo-3-phenyl-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-(3-methoxypropyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-3515
2-[4-(3-chlorophenyl)-1-(4-fluorophenyl)-7-oxo-3-phenyl-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-(3-methoxypropyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-3515

Molecular Formula

C30H28ClFN4O3S (C30 H28 ClFN4 O3 S)

Compound Name

2-[4-(3-chlorophenyl)-1-(4-fluorophenyl)-7-oxo-3-phenyl-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-(3-methoxypropyl)acetamide

IUPAC name

2-[4-(3-chlorophenyl)-1-(4-fluorophenyl)-7-oxo-3-phenyl-1H4H6H7H8H-pyrazolo[34-e][14]thiazepin-8-yl]-N-(3-methoxypropyl)acetamide

SMILES

COCCCNC(CN(c1c(C(c2cccc(Cl)c2)SC2)c(-c3ccccc3)nn1-c(cc1)ccc1F)C2=O)=O

InChI

InChI=1S/C30H28ClFN4O3S/c1-39-16-6-15-33-25(37)18-35-26(38)19-40-29(21-9-5-10-22(31)17-21)27-28(20-7-3-2-4-8-20)34-36(30(27)35)24-13-11-23(32)12-14-24/h2-5,7-14,17,29H,6,15-16,18-19H2,1H3,(H,33,37)/t29-/m1/s1

InChI Key

XEGGRZUKLMENJC-GDLZYMKVSA-N

MDL Number (MFCD)

MFCD19789683

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

579.09

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.304

Distribution Coefficient, logD

5.304

Water Solubility, LogSw

-5.85

Polar Surface Area

62.952

Acid Dissociation Constant (pKa)

15.65

Base Dissociation Constant (pKb)

4.52

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

23.30

V030-3515 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with V030-3515 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-3515?
Check Price and Availability of V030-3515, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-3515 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-3515
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-3515
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-3515 available by request